- Home
- GNK vs AQST Comparison
GNK vs AQST Comparison
Compare GNK & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNK | AQST |
|---|---|---|
| Founded | 2004 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 849.7M | 707.6M |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GNK | AQST |
|---|---|---|
| Price | $19.36 | $3.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $19.00 | $8.83 |
| AVG Volume (30 Days) | 346.7K | ★ 5.9M |
| Earning Date | 02-18-2026 | 03-04-2026 |
| Dividend Yield | ★ 7.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $331,332,000.00 | $43,397,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.38 | $43.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.20 | $2.12 |
| 52 Week High | $20.07 | $7.55 |
Technical Indicators
Market Signals| Indicator | GNK | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 58.70 | 20.39 |
| Support Level | $19.16 | $3.21 |
| Resistance Level | $19.72 | $3.60 |
| Average True Range (ATR) | 0.53 | 0.34 |
| MACD | 0.08 | -0.31 |
| Stochastic Oscillator | 69.73 | 2.81 |
Price Performance
Historical ComparisonAbout GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.